Reuters AlertNet Lite - Glaxo's Avandia should stay on market

Reuters AlertNet Full site

NEWSDESK

Glaxo's Avandia should stay on market - US panel

30 Jul 2007 21:41:28 GMT
Source: Reuters

GAITHERSBURG, Md., July 30 (Reuters) - GlaxoSmithKline Plc's <GSK.N> <GSK.L> diabetes drug Avandia should stay on the U.S. market even though data suggest it may raise the risk of a heart attack for some patients, an advisory panel said on Monday.

The Food and Drug Administration will consider the recommendation from outside experts but usually follows their advice.

AlertNet news is provided by

Email this article Send comments

NGO latest

• Countries devastated by global warming represented at WOMAD line-up
Christian Aid - UK

• ADRA's Response to 2007 Storms: Rapid, Global
ADRA - International

• CWS Appeal: 2007 summer flooding
CWS

• CWS situation report: Kansas flooding
CWS

• CWS situation report: Oklahoma flooding
CWS

MORE >>

Latest news

• Glaxo's Avandia should stay on market - US panel

• US soldier admits guilt to some charges in Iraq case

• Bush, Brown stress unity amid talk of cooler ties

• U.S. vehicles rank bottom in world fuel efficiency

• Taliban say kill hostage after demands are ignored

MORE >>

Last updated:Mon Jul 30 21:42:01 2007